COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 3015: Articles 30141-30150  | Next

Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China
Wen, Y., Wei, L., Li, Y., Tang, X., Feng, S., Leung, K., Wu, X., Pan, X.-F., Chen, C., Xia, J., Zou, X., Feng, T., Mei, S.
10.1101/2020.03.22.20035246 — Posted: 2020-03-23
Cross-reaction of sera from COVID-19 patients with SARS-CoV assays.
Wan, W. Y., Lim, S. H., Seng, E. H.
10.1101/2020.03.17.20034454 — Posted: 2020-03-23
Basic and effective reproduction numbers of COVID-19 cases in South Korea excluding Sincheonji cases
Hwang, J., Park, H., Jung, J., Kim, S.-H., Kim, N.
10.1101/2020.03.19.20039347 — Posted: 2020-03-23
COVID-19: Modelling Local Transmission and Morbidity effects to provide an estimate of overall Relative Healthcare Resource Impact by General Practice Granularity
Stedman, M., Lunt, M., Davies, M., Gibson, M., Heald, A.
10.1101/2020.03.20.20039024 — Posted: 2020-03-23
Optimization of Microbiological Laboratory Detection Strategy for Patients in A Designated Hospital Treating Novel Coronavirus Pneumonia in Anhui Province
Chang, W., Shi, Y., Qi, Y., Liu, J., Liu, T., Chen, Z., Zhang, W., Wang, M., Liu, D., Yin, M., Xu, J., Yang, Y., Zhu, X., Ge, J., Zhu, S., Gao, Y., Ma, X.
10.1101/2020.03.21.20039065 — Posted: 2020-03-23
The local stability of a modified multi-strain SIR model for emerging viral strains
Fudolig, M., Howard, R.
10.1101/2020.03.19.20039198 — Posted: 2020-03-23
An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
Li, Y., Xie, Z., Lin, W., Cai, W., Wen, C., Guan, Y., Mo, X., Wang, J., Wang, Y., Peng, P., Chen, X., Hong, W., Xiao, G., Liu, J., Zhang, L., Hu, F., Li, F., Li, F., Zhang, F., Deng, X., Li, L.
10.1101/2020.03.19.20038984 — Posted: 2020-03-23
AI-assisted CT imaging analysis for COVID-19 screening: Building and deploying a medical AI system in four weeks
Jin, S., Wang, B., Xu, H., Luo, C., Wei, L., Zhao, W., Hou, X., Ma, W., Xu, Z., Zheng, Z., Sun, W., Lan, L., Zhang, W., Mu, X., Shi, C., Wang, Z., Lee, J., Jin, Z., Lin, M., Jin, H., Zhang, L., Guo, J., Zhao, B., Ren, Z., Wang, S., You, Z., Dong, J., Wang, X., Wang, J., Xu, W.
10.1101/2020.03.19.20039354 — Posted: 2020-03-23
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability
Armijos-Jaramillo, V., Yeager, J., Muslin, C., Perez-Castillo, Y.
10.1101/2020.03.21.001933 — Posted: 2020-03-23
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Hüttenhain, R., Kaake, R. M., Richards, A. L., Tutuncuoglu, B., Foussard, H., Batra, J., Haas, K., Modak, M., Kim, M., Haas, P., Polacco, B. J., Braberg, H., Fabius, J. M., Eckhardt, M., Soucheray, M., Bennett, M. J., Cakir, M., McGregor, M. J., Li, Q., Naing, Z. Z., Zhou, Y., Peng, S., Kirby, I. T., Melnyk, J. E., Chorba, J. S., Lou, K., Dai, S. A., Shen, W., Shi, Y., Zhang, Z., Barrio-Hernandez, I., Memon, D., Hernandez-Armenta, C., Mathy, C. J., Perica, T., Pilla, K. B., Ganesan, S. J., Saltzberg, D. J., Ramachandran, R., Liu, X., Rosenthal, S. B., Calviello, L., Venkataramanan, S., Lin, Y., Wankowicz, S. A., Bohn, M., Trenker, R., Young, J. M., Cavero, D., Hiatt, J., Roth, T., Rathore, U., Subramanian, A., Noack, J., Hubert, M., Roesch, F., Vallet, T., Meyer, B., White, K. M., Miorin, L., Agard, D., Emerman, M., Ruggero, D., García-Sastre, A., Jura, N., Zastrow, M. v., Taunton, J., Schwartz, O., Vignuzzi, M., d’Enfert, C., Mukherjee, S., Jacobson, M., Malik, H. S., Fujimori, D. G., Ideker, T., Craik, C. S., Floor, S., Fraser, J. S., Gross, J., Sali, A., Kortemme, T., Beltrao, P., Shokat, K., Shoichet, B. K., Krogan, N. J.
10.1101/2020.03.22.002386 — Posted: 2020-03-22 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).